Urinary Peptidomic Analysis Identifies Potential Biomarkers for Acute Rejection of Renal Transplantation

The patients with acute vascular rejection were stratified into two subgroups: the steroid-tolera- ble subgroup and the steroid-sensitive sub- group; the real-time polymerase

Rapid steroid withdrawal versus standard steroid therapy in patients treated with basiliximab, cyclosporine, and mycophenolate mofetil for the prevention of acute

Increased C1 q -binding activity (C1 q -BA) was detected in 14 patients with acute rejection, 9 of whom had renal biopsies showing fibrin deposition in the vasculature together

Urinary biomarker incorporation into the renal angina index early in intensive care unit admission optimizes acute kidney injury prediction in critically ill children: a

To evaluate the phenotype of urinary CD4+ T cells, urine and blood samples of 10 SLE patients with acute proliferative LN were analyzed for various T cell surface markers as well

21 This principle was demon- strated in urine samples taken from sex-mismatched female renal transplant recipients, whereby patients who had experienced rejection had elevated levels

recommend use of rabbit anti-thymocyte globulin as induction therapy in renal transplant recipients at high immunologic risk for acute allograft rejection.. 1 The following

In this study we sought to test if the density and size of urinary EVs can be considered as potential biomarkers of early renal damage in DMt2 patients which can lead to